These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
315 related articles for article (PubMed ID: 28468758)
21. NK cells eliminate Epstein-Barr virus bound to B cells through a specific antibody-mediated uptake. Alari-Pahissa E; Ataya M; Moraitis I; Campos-Ruiz M; Altadill M; Muntasell A; Moles A; López-Botet M PLoS Pathog; 2021 Aug; 17(8):e1009868. PubMed ID: 34415956 [TBL] [Abstract][Full Text] [Related]
22. Expression of leukocyte immunoglobulin-like receptors and natural killer receptors on virus-specific CD8+ T cells during the evolution of Epstein-Barr virus-specific immune responses in vivo. Poon K; Montamat-Sicotte D; Cumberbatch N; McMichael AJ; Callan MF Viral Immunol; 2005; 18(3):513-22. PubMed ID: 16212530 [TBL] [Abstract][Full Text] [Related]
23. Comparative immunophenotypic features of EBV-positive and EBV-negative atypical lymphocytosis. Hudnall SD; Patel J; Schwab H; Martinez J Cytometry B Clin Cytom; 2003 Sep; 55(1):22-8. PubMed ID: 12949956 [TBL] [Abstract][Full Text] [Related]
24. Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults. Suzuki K; Ohshima K; Karube K; Suzumiya J; Ohga S; Ishihara S; Tamura K; Kikuchi M Int J Oncol; 2004 May; 24(5):1165-74. PubMed ID: 15067338 [TBL] [Abstract][Full Text] [Related]
25. Dimorphism in the TCRγ-chain repertoire defines 2 types of human immunity to Epstein-Barr virus. Djaoud Z; Parham P Blood Adv; 2020 Apr; 4(7):1198-1205. PubMed ID: 32211881 [TBL] [Abstract][Full Text] [Related]
27. Innate Immune Recognition of EBV. Lünemann A; Rowe M; Nadal D Curr Top Microbiol Immunol; 2015; 391():265-87. PubMed ID: 26428378 [TBL] [Abstract][Full Text] [Related]
28. Hydroa vacciniforme is associated with increased numbers of Epstein-Barr virus-infected γδT cells. Hirai Y; Yamamoto T; Kimura H; Ito Y; Tsuji K; Miyake T; Morizane S; Suzuki D; Fujii K; Iwatsuki K J Invest Dermatol; 2012 May; 132(5):1401-8. PubMed ID: 22297643 [TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr virus coinfection in children boosts cytomegalovirus-induced differentiation of natural killer cells. Saghafian-Hedengren S; Sohlberg E; Theorell J; Carvalho-Queiroz C; Nagy N; Persson JO; Nilsson C; Bryceson YT; Sverremark-Ekström E J Virol; 2013 Dec; 87(24):13446-55. PubMed ID: 24089567 [TBL] [Abstract][Full Text] [Related]
30. Tonsilar NK cells restrict B cell transformation by the Epstein-Barr virus via IFN-gamma. Strowig T; Brilot F; Arrey F; Bougras G; Thomas D; Muller WA; Münz C PLoS Pathog; 2008 Feb; 4(2):e27. PubMed ID: 18266470 [TBL] [Abstract][Full Text] [Related]
31. gammadelta-T cells expressing NK receptors predominate over NK cells and conventional T cells in the innate IFN-gamma response to Plasmodium falciparum malaria. D'Ombrain MC; Hansen DS; Simpson KM; Schofield L Eur J Immunol; 2007 Jul; 37(7):1864-73. PubMed ID: 17557374 [TBL] [Abstract][Full Text] [Related]
33. Skewed T cell receptor repertoire of Vdelta1(+) gammadelta T lymphocytes after human allogeneic haematopoietic stem cell transplantation and the potential role for Epstein-Barr virus-infected B cells in clonal restriction. Fujishima N; Hirokawa M; Fujishima M; Yamashita J; Saitoh H; Ichikawa Y; Horiuchi T; Kawabata Y; Sawada KI Clin Exp Immunol; 2007 Jul; 149(1):70-9. PubMed ID: 17425654 [TBL] [Abstract][Full Text] [Related]
34. Characterization of skin blister fluids from children with Epstein-Barr virus-associated lymphoproliferative disease. Wada T; Toma T; Miyazawa H; Koizumi E; Shirahashi T; Matsuda Y; Yachie A J Dermatol; 2018 Apr; 45(4):444-449. PubMed ID: 29352500 [TBL] [Abstract][Full Text] [Related]
35. Increased expression of Toll-like receptors 7 and 9 in myasthenia gravis thymus characterized by active Epstein-Barr virus infection. Cavalcante P; Galbardi B; Franzi S; Marcuzzo S; Barzago C; Bonanno S; Camera G; Maggi L; Kapetis D; Andreetta F; Biasiucci A; Motta T; Giardina C; Antozzi C; Baggi F; Mantegazza R; Bernasconi P Immunobiology; 2016 Apr; 221(4):516-27. PubMed ID: 26723518 [TBL] [Abstract][Full Text] [Related]
36. EBV induces persistent NF-κB activation and contributes to survival of EBV-positive neoplastic T- or NK-cells. Takada H; Imadome KI; Shibayama H; Yoshimori M; Wang L; Saitoh Y; Uota S; Yamaoka S; Koyama T; Shimizu N; Yamamoto K; Fujiwara S; Miura O; Arai A PLoS One; 2017; 12(3):e0174136. PubMed ID: 28346502 [TBL] [Abstract][Full Text] [Related]
37. The T-cell Response to Epstein-Barr Virus-New Tricks From an Old Dog. Long HM; Meckiff BJ; Taylor GS Front Immunol; 2019; 10():2193. PubMed ID: 31620125 [TBL] [Abstract][Full Text] [Related]
38. T/NK cell type chronic active Epstein-Barr virus disease in adults: an underlying condition for Epstein-Barr virus-associated T/NK-cell lymphoma. Isobe Y; Aritaka N; Setoguchi Y; Ito Y; Kimura H; Hamano Y; Sugimoto K; Komatsu N J Clin Pathol; 2012 Mar; 65(3):278-82. PubMed ID: 22247563 [TBL] [Abstract][Full Text] [Related]
39. A distinct subpopulation of human NK cells restricts B cell transformation by EBV. Lünemann A; Vanoaica LD; Azzi T; Nadal D; Münz C J Immunol; 2013 Nov; 191(10):4989-95. PubMed ID: 24108698 [TBL] [Abstract][Full Text] [Related]
40. Epstein-Barr virus microRNAs reduce immune surveillance by virus-specific CD8+ T cells. Albanese M; Tagawa T; Bouvet M; Maliqi L; Lutter D; Hoser J; Hastreiter M; Hayes M; Sugden B; Martin L; Moosmann A; Hammerschmidt W Proc Natl Acad Sci U S A; 2016 Oct; 113(42):E6467-E6475. PubMed ID: 27698133 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]